A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.

ABSTRACT:

SUBMITTER: Tai W 

PROVIDER: S-EPMC7403570 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature